Penumbra
PEN
#1772
Rank
S$12.64 B
Marketcap
$329.36
Share price
1.81%
Change (1 day)
5.49%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Earnings for Penumbra (PEN)

Earnings in 2024 (TTM): -S$4.92 Million

According to Penumbra's latest financial reports the company's current earnings are S$1.16 Billion. In 2023 the company made an earning of S$0.11 Billion, an increase over its 2022 earnings that were of S$8.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Penumbra from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$4.92 Million-104.37%
2023 S$0.11 B1272.57%
2022 S$8.18 M-181.08%
2021 -S$10.1 Million-80.74%
2020 -S$52.39 Million-181.97%
2019 S$63.9 M58.45%
2018 S$40.33 M2473.65%
2017 S$1.56 M-186.3%
2016 -S$1.82 Million-132.3%
2015 S$5.62 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$71.37 Million 7,901.96%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.23 B-26,724.13%๐Ÿ‡บ๐Ÿ‡ธ USA